cauti-banner

Research Investigators

Prof Brett Mitchell, Dr Oyebola Fasugba – Avondale College
Prof Anne Gardner, Dr Jane Koerner – Australian Catholic University
Prof Allen Cheng – Monash University
Prof Peter Collignon – Australian National University & ACT Pathology
Prof Nicholas Grave – QUT
Project Manager: Victoria Gregory
Contact Us: CAUTI@avondale.edu.au Tel: 02 9480 3612

Background

Approximately 1% of all patients who go to hospital acquire a urinary tract infection (around 95,000 patients per year in Australia)

Insertion of the catheter is an important part of reducing the risk of infection for patients. There are benefits not only to patients in reducing the risk of infection, but also potential cost savings from reducing infections, characterised by the bed days saved from keeping patients infection free and hence discharging them earlier.

Further evidence is required in order to ascertain if cleaning the urethral meatus with saline or an antiseptic such as chlorhexidine will reduce the instances of infection. National and international guidelines are also unclear on which is better.

The findings from this research will demonstrate whether investing in the use of chlorhexidine will improve cost-effectiveness and reduce the risks of infection.

To achieve this, a team of researchers, in partnership with Sydney Adventist, Canberra and Lismore hospitals, are conducting this clinical trial comparing saline vs chlorhexidine in patients receiving a catheter.

The findings will inform national recommendations, such as the NHMRC infection control guidelines. In turn, this will positively impact on the quality of patient care provided, by ensuring procedures that minimise the risk of infection are used.

Canberra Hospital

Control Phase

01.08.2017 – 25.09.2017
SALINE

Intervention Phase

26.09.2017 – 12.03.2018
CHLORHEXIDINE

Lismore Hospital

Control Phase

01.08.2017 – 20.11.2017
SALINE

Intervention Phase

21.11.2017 – 12.03.2017
CHLORHEXIDINE

Sydney Adventist Hospital

Control Phase

01.08.2017 – 15.01.2018
SALINE

Intervention Phase

16.01.2017 – 12.03.2017
CHLORHEXIDINE